JP2013543721A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543721A5 JP2013543721A5 JP2013530426A JP2013530426A JP2013543721A5 JP 2013543721 A5 JP2013543721 A5 JP 2013543721A5 JP 2013530426 A JP2013530426 A JP 2013530426A JP 2013530426 A JP2013530426 A JP 2013530426A JP 2013543721 A5 JP2013543721 A5 JP 2013543721A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- acid sequence
- homologous
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical group 0.000 claims 294
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 281
- 239000012634 fragment Substances 0.000 claims 132
- 230000002163 immunogen Effects 0.000 claims 114
- 108090000623 proteins and genes Proteins 0.000 claims 108
- 102000004169 proteins and genes Human genes 0.000 claims 108
- 241000223960 Plasmodium falciparum Species 0.000 claims 57
- 239000002773 nucleotide Substances 0.000 claims 21
- 125000003729 nucleotide group Chemical group 0.000 claims 21
- 229960005486 vaccine Drugs 0.000 claims 16
- 101100038180 Caenorhabditis briggsae rpb-1 gene Proteins 0.000 claims 10
- 239000013612 plasmid Substances 0.000 claims 8
- 201000004792 malaria Diseases 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 6
- 102000039446 nucleic acids Human genes 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 102000001327 Chemokine CCL5 Human genes 0.000 claims 1
- 108010055166 Chemokine CCL5 Proteins 0.000 claims 1
- 102100020992 Interferon lambda-3 Human genes 0.000 claims 1
- 101710099621 Interferon lambda-3 Proteins 0.000 claims 1
- 102000013462 Interleukin-12 Human genes 0.000 claims 1
- 108010065805 Interleukin-12 Proteins 0.000 claims 1
- 102000003812 Interleukin-15 Human genes 0.000 claims 1
- 108090000172 Interleukin-15 Proteins 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38697310P | 2010-09-27 | 2010-09-27 | |
| US61/386,973 | 2010-09-27 | ||
| PCT/US2011/053541 WO2012047679A2 (en) | 2010-09-27 | 2011-09-27 | Consensus antigen constructs and vaccines made there form, and methods of using same to treat malaria |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013543721A JP2013543721A (ja) | 2013-12-09 |
| JP2013543721A5 true JP2013543721A5 (https=) | 2014-11-13 |
| JP6293485B2 JP6293485B2 (ja) | 2018-03-14 |
Family
ID=45928328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013530426A Expired - Fee Related JP6293485B2 (ja) | 2010-09-27 | 2011-09-27 | コンセンサス抗原コンストラクトおよびそれらから作製されるワクチン、ならびにそれらを使用するマラリアの治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10799572B2 (https=) |
| EP (1) | EP2621540A4 (https=) |
| JP (1) | JP6293485B2 (https=) |
| KR (2) | KR20180096814A (https=) |
| CN (2) | CN110195069A (https=) |
| AU (1) | AU2011312465B2 (https=) |
| BR (1) | BR112013007051A2 (https=) |
| CA (1) | CA2812789A1 (https=) |
| MX (1) | MX355501B (https=) |
| WO (1) | WO2012047679A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2796147A1 (en) * | 2013-04-24 | 2014-10-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Novel vaccines against apicomplexan pathoges |
| EP2923709A1 (en) * | 2014-03-28 | 2015-09-30 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Multi-component-multistage malaria vaccine |
| EP2992895A1 (en) | 2014-09-08 | 2016-03-09 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Three-component-multistage malaria vaccine |
| CN105628928A (zh) * | 2014-11-11 | 2016-06-01 | 深圳国际旅行卫生保健中心 | 可用于辅助诊断疟疾的试剂盒 |
| KR20170103874A (ko) * | 2015-01-23 | 2017-09-13 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 돼지 유행성 설사병 바이러스를 위한 최적화된 합성 컨센서스 dna 백신의 면역원성 |
| EP3081575A1 (en) * | 2015-04-12 | 2016-10-19 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anti-plasmodium parasite antibodies |
| US12544441B2 (en) | 2016-11-01 | 2026-02-10 | Washington University | Compositions comprising CelTOS immunogens and antibodies and method of use thereof |
| US12398184B2 (en) | 2016-11-01 | 2025-08-26 | Washington University | Compositions comprising CelTOS immunogens and antibodies and method of use thereof |
| CN110418648B (zh) * | 2017-02-22 | 2023-09-08 | 丁恩雨 | 一种编码人GM-CSF与多串连表位融合的mRNA癌症疫苗 |
| CN109125740B (zh) * | 2017-06-28 | 2022-04-05 | 成都威斯克生物医药有限公司 | 一种新型的肿瘤疫苗及其用途 |
| KR102169664B1 (ko) * | 2019-02-26 | 2020-10-23 | 원광대학교산학협력단 | 열대열말라리아원충 유래의 EF-1α 재조합 단백질을 유효성분으로 포함하는 말라리아 예방용 백신 조성물 |
| US20240148854A1 (en) * | 2021-03-26 | 2024-05-09 | The Wistar Institute Of Anatomy And Biology | DNA Encoded Nanoparticle Vaccine Against Human Papillomavirus, and Methods of Use Thereof |
| WO2025024337A1 (en) * | 2023-07-24 | 2025-01-30 | BioNTech SE | Compositions for delivery of plasmodium antigens and related methods |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| EP0646178A1 (en) | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
| US5273525A (en) | 1992-08-13 | 1993-12-28 | Btx Inc. | Injection and electroporation apparatus for drug and gene delivery |
| HU219767B (hu) | 1993-01-26 | 2001-07-30 | Leslie R. Coney | Készítmények és eljárások genetikai anyag sejtbe történő beviteléhez |
| CA2285056C (en) | 1997-04-03 | 2004-12-14 | Iacob Mathiesen | Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle |
| US6261281B1 (en) | 1997-04-03 | 2001-07-17 | Electrofect As | Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| AU8444798A (en) | 1997-06-30 | 1999-01-25 | Centre National De La Recherche Scientifique | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| US6697669B2 (en) | 1998-07-13 | 2004-02-24 | Genetronics, Inc. | Skin and muscle-targeted gene therapy by pulsed electrical field |
| US8209006B2 (en) | 2002-03-07 | 2012-06-26 | Vgx Pharmaceuticals, Inc. | Constant current electroporation device and methods of use |
| US7245963B2 (en) | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
| US7328064B2 (en) | 2002-07-04 | 2008-02-05 | Inovio As | Electroporation device and injection apparatus |
| NZ539813A (en) | 2002-12-17 | 2008-04-30 | Crucell Holland Bv | A replication defective recombinant adenovirus comprising a antigenic determinant of Plasmodium falciparum wherein the antigenic determinant is SEQ ID 6 |
| WO2004108260A2 (en) | 2003-05-30 | 2004-12-16 | Advisys, Inc. | Devices and methods for biomaterial production |
| US7981601B2 (en) | 2003-08-01 | 2011-07-19 | Institute Of Basic Medical Sciences | Method of preparing polyepitope chimeric gene vaccine |
| US8168166B2 (en) | 2003-12-19 | 2012-05-01 | Seattle Biomedical Research Institute | Live genetically attenuated malaria vaccine |
| BRPI0615400A2 (pt) | 2005-08-31 | 2011-05-17 | Genvec Inc | vacinas para malária baseadas em vetor adenoviral |
| KR20100068390A (ko) * | 2007-08-13 | 2010-06-23 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| KR101652767B1 (ko) * | 2008-04-04 | 2016-08-31 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Ｉｌ-28을 이용한 백신 및 면역치료제, 및 그를 사용하는 방법 및 조성물 |
| US9120868B2 (en) | 2008-11-25 | 2015-09-01 | The United States of America as Represented by the Secratary of the Army | Recombinantly expressed Plasmodium CelTOS antigen and methods of use thereof |
| US20110229514A1 (en) | 2009-03-16 | 2011-09-22 | Denise Doolan | Vaccine and immunization method using plasmodium antigen 2 |
-
2011
- 2011-09-27 MX MX2013003470A patent/MX355501B/es active IP Right Grant
- 2011-09-27 CN CN201910279715.8A patent/CN110195069A/zh active Pending
- 2011-09-27 JP JP2013530426A patent/JP6293485B2/ja not_active Expired - Fee Related
- 2011-09-27 CN CN2011800513670A patent/CN103354750A/zh active Pending
- 2011-09-27 BR BR112013007051A patent/BR112013007051A2/pt not_active Application Discontinuation
- 2011-09-27 KR KR1020187023719A patent/KR20180096814A/ko not_active Abandoned
- 2011-09-27 US US13/876,148 patent/US10799572B2/en active Active
- 2011-09-27 CA CA2812789A patent/CA2812789A1/en not_active Abandoned
- 2011-09-27 WO PCT/US2011/053541 patent/WO2012047679A2/en not_active Ceased
- 2011-09-27 KR KR1020137010740A patent/KR101891195B1/ko not_active Expired - Fee Related
- 2011-09-27 AU AU2011312465A patent/AU2011312465B2/en not_active Ceased
- 2011-09-27 EP EP11831320.4A patent/EP2621540A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013543721A5 (https=) | ||
| Wang et al. | Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein | |
| Zhang et al. | Recent advances in developing vaccines against Toxoplasma gondii: an update | |
| Roose et al. | Hepatitis B core–based virus–like particles to present heterologous epitopes | |
| Doll et al. | Discriminating protective from nonprotective Plasmodium-specific CD8+ T cell responses | |
| EP3244915A1 (en) | Virus-like particle with efficient epitope display | |
| RU2012110255A (ru) | Модификация рекомбинантного аденовируса иммуногенными эпитопами белка circumsporozoite плазмодия | |
| JP2016523821A5 (https=) | ||
| Leclerc | New approaches in vaccine development | |
| US20120015000A1 (en) | Malaria vaccine of self-assembling polypeptide nanoparticles | |
| WO2016016651A2 (en) | Treatment and prevention of malaria | |
| Apte et al. | Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria model | |
| Biswas et al. | Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection | |
| Gilbert et al. | Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations | |
| PT2059525E (pt) | Partículas split-core para a apresentação de moléculas estranhas, principalmente para utilização em vacinas e processos para a sua produção | |
| Almeida et al. | Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein | |
| CN101643497A (zh) | Lmp2a蛋白来源的hla-a2限制性表位多肽及其用途 | |
| US11129882B2 (en) | Virus like particle with efficient epitope display | |
| CN102000330B (zh) | 一种核酸疫苗佐剂及其构建方法 | |
| AU2011314630B2 (en) | Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses | |
| WO2014186409A1 (en) | Immunogenic compositions for inhibiting hepatitis d virus | |
| Dobaño et al. | Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity | |
| WO2018055331A1 (en) | Thermostable variants of p. falciparum pfrh5 which can be produced in bacterial cells | |
| Kanoi et al. | New concepts in vaccine development in malaria | |
| Stirling et al. | Modifying non-coding regions of linear DNA vaccines to explore the interplay of expression and inflammation in immunogenicity |